IGFBP2 and metabolic dysfunction-associated steatotic liver disease: Regarding metabolic abnormalities, including NAFLD, low levels of IGFBP-2 have been reported in obesity, type 2 diabetes, and metabolic syndrome [20], whereas IGFBP-5 is increased in NASH [21].